14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
GNMX vs AKTX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Akari Therapeutics plc (AKTX) is the stronger overall head-to-head candidate over GNMX (GNMX) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 2–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). GNMX carries a Unified Composite Score of 53.1/100 (HOLD) at $32.06 (N/M Forward P/E, N/A operating margin), whereas AKTX carries 50.1/100 (HOLD) at $7.18 (N/M Forward P/E, 0.0% operating margin).
Composite vs. Pillar Nuance: While GNMX currently prints a higher short-term Unified Composite Score (53.1/100 HOLD vs. AKTX 50.1/100 HOLD), AKTX captures the overall institutional head-to-head verdict (5–3 matrix metrics and 2–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. N/A operating margin) and revenue trajectory (+0.0% vs. N/A YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNMX vs AKTX. Trailing 12-month operating profitability (GNMX N/A vs AKTX 0.0%) and valuation multiples (GNMX N/M vs AKTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $15.6M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ GNMX vs AKTX Key Questions & Quantitative Answers
As of Nov 20, 2026, Akari Therapeutics plc (AKTX) is the stronger overall head-to-head candidate over GNMX (GNMX) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 2–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). GNMX carries a Unified Composite Score of 53.1/100 (HOLD) at $32.06 (N/M Forward P/E, N/A operating margin), whereas AKTX carries 50.1/100 (HOLD) at $7.18 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While GNMX currently prints a higher short-term Unified Composite Score (53.1/100 HOLD vs. AKTX 50.1/100 HOLD), AKTX captures the overall institutional head-to-head verdict (5–3 matrix metrics and 2–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. N/A operating margin) and revenue trajectory (+0.0% vs. N/A YoY).
AKTX leads the Growth & Scale pillar: GNMX posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with AKTX at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, GNMX generates N/A in USD-normalized revenue versus N/A for AKTX. In operating R&D and SG&A reinvestment, GNMX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AKTX.
GNMX and AKTX trade at balanced relative valuation multiples. GNMX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas AKTX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GNMX (N/A ROE) versus AKTX (-146.3% ROE) capital efficiency.
In options market volatility and institutional positioning, GNMX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.19β · 44% Vol realized risk). By comparison, AKTX carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (77.35β · 143% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.